Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. - Wikidata - awgldk - TriplyDB

Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.

Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.

http://www.wikidata.org/entity/Q38451147

about

Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease Action plans for COPD: strategies to manage exacerbations and improve outcomes Acute exacerbation of COPD Exacerbations of COPD Adjunctive Systemic Corticosteroids for Hospitalized Community-Acquired Pneumonia: Systematic Review and Meta-Analysis 2015 Update Systemic corticosteroids in acute exacerbation of COPD: a meta-analysis of controlled studies with emphasis on ICU patients Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease When should acute exacerbations of COPD be treated with systemic corticosteroids and antibiotics in primary care: a systematic review of current COPD guidelines Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management Expert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People's Republic of China ATS Core Curriculum 2016: Part II. Adult Critical Care Medicine.Dynamics of inflammation resolution and symptom recovery during AECOPD treatment.Corticosteroid treatment for community-acquired pneumonia--the STEP trial: study protocol for a randomized controlled trial Differences in classification of COPD patients into risk groups A-D: a cross-sectional study.Distinguishing adult-onset asthma from COPD: a review and a new approach.Study of drug utilization pattern for acute exacerbation of chronic obstructive pulmonary disease in patients attending a government hospital in kerala, India Chronic obstructive pulmonary disease: respiratory review of 2014.Systemic steroids in COPD-the beauty and the beast.Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.Standards of suitability for the management of chronic obstructive respiratory diseases Randomized double blind placebo-controlled study to demonstrate that antibiotics are not needed in moderate acute exacerbations of COPD--the ABACOPD study.Osteoporosis in chronic obstructive pulmonary disease Improving adherence for management of acute exacerbation of chronic obstructive pulmonary disease.C-reactive protein and N-terminal prohormone brain natriuretic peptide as biomarkers in acute exacerbations of COPD leading to hospitalizations.POPE study: rationale and methodology of a study to phenotype patients with COPD in Central and Eastern Europe.The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients.Differences in care between general medicine and respiratory specialists in the management of patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease Pharmacological Management and Prevention Of Exacerbations of Chronic Obstructive Pulmonary Disease in Hospitalized Patients.Steroids for acute COPD--but for how long?The Saudi Guidelines for the Diagnosis and Management of COPD.Chronic obstructive pulmonary disease: clinical review and update on consensus guidelines.Level of adherence to the GOLD strategy document for management of patients admitted to hospital with an acute exacerbation of COPD.Acute exacerbations of chronic obstructive pulmonary disease: diagnosis, management, and prevention in critically ill patients.Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment.High-Dose Versus Low-Dose Systemic Steroids in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Systematic Review Recent updates in chronic obstructive pulmonary disease.COPD Readmissions: Addressing COPD in the Era of Value-based Health Care.COPD-associated pulmonary hypertension: clinical implications and current methods for treatment.Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.

P2860

Q24187361-FC456438-566A-4A3A-B4D3-704F82FABE13 Q26744059-23DE3A5E-B1B7-4C60-AAA3-E7D5EF2F467D Q26749302-06A0149A-CE69-4817-8C4E-D2CC591D0309 Q26764891-DDEF3177-8EB3-4AA8-92F1-52885EED2071 Q26786793-719B4F3F-43F9-465C-804B-EFCA7A7ECF02 Q27010596-884226F7-51C4-482A-B019-D7D7C76947ED Q27023118-6909D7CC-B671-4263-904E-2142A05CCCA8 Q28085429-289AF506-5B75-48AB-B898-54CE89CB70B4 Q30368680-E448B114-8E23-4537-B98D-27B8D318B8BC Q33559286-194AD1C5-C113-4FC3-886D-ED76A5257C23 Q33772360-6FDDEE70-B017-45F5-BD51-80E17534DBC3 Q33827166-5A070D1B-BD3B-45DE-9294-56A39EFDEFB6 Q33853198-7A270E45-D325-440F-88BE-C1BB84052283 Q34107700-7805F9F3-0A70-4CB9-8CE4-CE426B010A70 Q34198033-492DD482-4126-4764-9E75-E8A37BC7A93A Q34405926-2F64B4A5-54EF-47F1-9490-CC8FE3DF8E1B Q34440060-082860FF-A087-42D7-BFF1-AADC052C357C Q34525148-D6846134-7C83-4B29-9F81-C85828A4AD27 Q34550471-49302BA6-7003-49FD-BC7A-AFD606A595D8 Q34911219-8A2C493C-E14E-4FE8-937B-79B56E93246E Q35149431-844BC944-F150-4A00-A119-351862B374B9 Q35173349-A10BF6A2-9D05-4FF7-9338-467A0C20C1C2 Q36117064-9F26187F-613A-4083-8361-1082CCFABBE2 Q36318334-EA2F9B4D-6AC0-49E1-8D2F-F2CC3BFA2802 Q36733544-08973700-0D71-4AE2-9A20-476183D0A08D Q36763617-E235CA23-916C-48A2-97B2-28162B1C1EAA Q37158368-F0D99191-A583-40C0-81DC-4C863129712B Q37290398-1ACD807F-B3FF-485C-9F53-1DBD808DBF92 Q37372207-0D24A8A0-B5BD-4254-A2C8-4FE07B6AB827 Q37473495-3CE17AEE-5B08-4384-AF54-911E60C1B13C Q37733309-8F233B93-C7E7-45D4-8ED5-ABDAD41A1DC3 Q38190849-C5285329-C5DE-41D1-B4F0-5FE2ED8437A9 Q38239940-50286D44-7C70-4FC9-9EBF-2CD5E6F52CEA Q38511557-02CF323C-1321-4F4A-94C9-4F71BD1E75F3 Q38550921-09869A8C-2B98-4EA1-BB43-6C5FB9FC841F Q38604638-C4AFE13E-DAAD-4A1B-B8DA-2719C6E1D334 Q38631285-D51338AE-D31C-46D6-B298-E166A3DE92B8 Q38831794-55E2E5C2-72EB-4A6A-81C9-F77C074B8D09 Q38841456-F2C55539-1D73-4EDD-8E54-6ECCDF714996 Q38934768-2117150D-0BF7-48B7-A8CA-DA6F98E99D40

P2860

Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.

http://www.wikidata.org/entity/Q38451147

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Short-term vs conventional glu ...... UCE randomized clinical trial.

@en

type

label

Short-term vs conventional glu ...... UCE randomized clinical trial.

@en

prefLabel

Short-term vs conventional glu ...... UCE randomized clinical trial.

@en

P1433

Q38451147-EC16146B-BE65-4084-813B-73D468B8F6A2

P1476

Q38451147-5468316F-5B1F-4C32-9B20-BDD9C0B26FE6

P2093

Q38451147-040BFC7F-C486-4D19-B97D-1968AD2633AC

Q38451147-14E2C9AE-3C8A-46F5-B346-D2590C40C1C3

Q38451147-2709332A-C595-4C25-8501-E9B7F4E06835

Q38451147-4A712B32-C448-4EC0-9DFF-ADC8E290E011

Q38451147-5579B649-2BFE-45AF-8D24-83E30FD9F337

Q38451147-700E2BF9-4B1B-4A77-BB62-0E5802FED7BD

Q38451147-792C1CFA-C6A8-4CA6-B11B-CBCB8C762146

Q38451147-8C47174F-0925-402C-A548-5837A0A3C721

Q38451147-9ED89A39-7CF1-4B21-A765-DD54D8E74E01

Q38451147-B65E0C33-FE4D-4E81-ACE3-1D7A90A8E8EE

P304

Q38451147-1F97F67F-2E0E-457A-A62A-8D230DAA2EA3

P31

Q38451147-9D116F6F-9F81-4324-A9A7-CE301ACF5BC9

P356

Q38451147-AC22B9CE-7083-463D-B836-C6456BB714FB

P407

Q38451147-09C50A72-4AB3-444A-9796-B2F1D6837DA4

P433

Q38451147-6ACC77FE-E711-4264-B260-F8412A2C3294

P478

Q38451147-77FE2A4E-ACE6-403B-A92D-36B1792A0903

P50

Q38451147-6F9D052B-CFBA-49E7-8C36-7DB4B315F349

Q38451147-C1BCD056-1B9B-4A59-93B1-1F6D19D90030

P577

Q38451147-E153F82F-5474-49D7-B314-8AD24F5A90B3

P5875

Q38451147-01B41B88-56BF-455C-A7FE-B25C5A2E0D42

P698

Q38451147-4ABD0047-E012-4232-B669-1CDF8BA03A4D

P921

Q38451147-BE5E3957-593A-4691-BC77-C3C1C1024989

P356

P1433

Journal of the American Medical Association

P1476

Short-term vs conventional glu ...... UCE randomized clinical trial.

@en

P2093

Andreas Scherr

http://www.w3.org/2001/XMLSchema#string

Beat Müller

http://www.w3.org/2001/XMLSchema#string

Christian Schindler

http://www.w3.org/2001/XMLSchema#string

Christoph Henzen

http://www.w3.org/2001/XMLSchema#string

Christophe von Garnier

http://www.w3.org/2001/XMLSchema#string

David Miedinger

http://www.w3.org/2001/XMLSchema#string

Jonas Rutishauser

http://www.w3.org/2001/XMLSchema#string

Jörg D Leuppi

http://www.w3.org/2001/XMLSchema#string

Michael Bodmer

http://www.w3.org/2001/XMLSchema#string

Michael Tamm

http://www.w3.org/2001/XMLSchema#string

P304

2223-2231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2013.5023

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

309

http://www.w3.org/2001/XMLSchema#string

P50

Roland Bingisser

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236929245

http://www.w3.org/2001/XMLSchema#string

P698

23695200

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease